Oncology and Therapy (Nov 2023)

Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?

  • Heidi Ko,
  • Rebecca A. Previs,
  • Kyle C. Strickland,
  • Jonathan Klein,
  • Brian Caveney,
  • Chiara Chiruzzi,
  • Marcia Eisenberg,
  • Eric A. Severson,
  • Shakti Ramkissoon,
  • Kamal S. Saini

DOI
https://doi.org/10.1007/s40487-023-00249-0
Journal volume & issue
Vol. 12, no. 1
pp. 13 – 17

Abstract

Read online

No abstracts available.

Keywords